trending Market Intelligence /marketintelligence/en/news-insights/trending/2bi6tAHYmH9NRDOyj1_5zg2 content esgSubNav
In This List

Oncimmune replaces outgoing CFO

Blog

Insight Weekly: Ukraine war impact on mining; US bank growth slowdown; cloud computing headwinds

Blog

Insight Weekly: Cryptocurrency's growth; green bond market outlook; coal investors' windfall

Blog

Global M&A By the Numbers: Q1 2022

Blog

Insight Weekly: Challenges for European banks; Japan's IPO slowdown; carmakers' supply woes


Oncimmune replaces outgoing CFO

Oncimmune Holdings PLC director and CFO Andrew Millet has stepped down but will remain with the company for six months to ensure an orderly transition.

The company appointed Matthew Hall to replace Millet. Hall recently served as CFO at Tusk Therapeutics and Simbec-Orion Group.

Oncimmune is an early-cancer detection company.